Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 283 entries
Sorted by: Best Match Show Resources per page
Long term combination treatment for severe idiopathic pulmonary arterial hypertension.

World journal of cardiology

Affuso F, Cirillo P, Ruvolo A, Carlomagno G, Fazio S.
PMID: 21160759
World J Cardiol. 2010 Mar 26;2(3):68-70. doi: 10.4330/wjc.v2.i3.68.

We report the long-term follow-up of 3 cases of severe idiopathic pulmonary arterial hypertension, in whom tadalafil plus sitaxentan combination therapy improved the clinical condition and exercise performance without any relevant adverse event.

Cite
Affuso F, Cirillo P, Ruvolo A, et al. Long term combination treatment for severe idiopathic pulmonary arterial hypertension. World J Cardiol. 2010;2(3):68-70doi: 10.4330/wjc.v2.i3.68.
Affuso, F., Cirillo, P., Ruvolo, A., Carlomagno, G., & Fazio, S. (2010). Long term combination treatment for severe idiopathic pulmonary arterial hypertension. World journal of cardiology, 2(3), 68-70. https://doi.org/10.4330/wjc.v2.i3.68
Affuso, Flora, et al. "Long term combination treatment for severe idiopathic pulmonary arterial hypertension." World journal of cardiology vol. 2,3 (2010): 68-70. doi: https://doi.org/10.4330/wjc.v2.i3.68
Affuso F, Cirillo P, Ruvolo A, Carlomagno G, Fazio S. Long term combination treatment for severe idiopathic pulmonary arterial hypertension. World J Cardiol. 2010 Mar 26;2(3):68-70. doi: 10.4330/wjc.v2.i3.68. PMID: 21160759; PMCID: PMC2999023.
Copy Download .nbib Format: NLM
Direct patterning of silver particles on porous silicon by inkjet printing of a silver salt via in-situ reduction.

Nanoscale research letters

Chiolerio A, Virga A, Pandolfi P, Martino P, Rivolo P, Geobaldo F, Giorgis F.
PMID: 22953722
Nanoscale Res Lett. 2012 Sep 06;7(1):502. doi: 10.1186/1556-276X-7-502.

We have developed a method for obtaining a direct pattern of silver nanoparticles (NPs) on porous silicon (p-Si) by means of inkjet printing (IjP) of a silver salt. Silver NPs were obtained by p-Si mediated in-situ reduction of Ag+...

Cite
Chiolerio A, Virga A, Pandolfi P, et al. Direct patterning of silver particles on porous silicon by inkjet printing of a silver salt via in-situ reduction. Nanoscale Res Lett. 2012;7(1):502doi: 10.1186/1556-276X-7-502.
Chiolerio, A., Virga, A., Pandolfi, P., Martino, P., Rivolo, P., Geobaldo, F., & Giorgis, F. (2012). Direct patterning of silver particles on porous silicon by inkjet printing of a silver salt via in-situ reduction. Nanoscale research letters, 7(1), 502. https://doi.org/10.1186/1556-276X-7-502
Chiolerio, Alessandro, et al. "Direct patterning of silver particles on porous silicon by inkjet printing of a silver salt via in-situ reduction." Nanoscale research letters vol. 7,1 (2012): 502. doi: https://doi.org/10.1186/1556-276X-7-502
Chiolerio A, Virga A, Pandolfi P, Martino P, Rivolo P, Geobaldo F, Giorgis F. Direct patterning of silver particles on porous silicon by inkjet printing of a silver salt via in-situ reduction. Nanoscale Res Lett. 2012 Sep 06;7(1):502. doi: 10.1186/1556-276X-7-502. PMID: 22953722; PMCID: PMC3526385.
Copy Download .nbib Format: NLM
On the shoulders of giants: a 1500-year-old aphorism.

The American journal of medicine

Dorizzi RM, Sette P, Azzini AM.
PMID: 25107403
Am J Med. 2014 Aug;127(8):e41. doi: 10.1016/j.amjmed.2014.03.036.

No abstract available.

Cite
Dorizzi RM, Sette P, Azzini AM. On the shoulders of giants: a 1500-year-old aphorism. Am J Med. 2014;127(8):e41doi: 10.1016/j.amjmed.2014.03.036.
Dorizzi, R. M., Sette, P., & Azzini, A. M. (2014). On the shoulders of giants: a 1500-year-old aphorism. The American journal of medicine, 127(8), e41. https://doi.org/10.1016/j.amjmed.2014.03.036
Dorizzi, Romolo M, et al. "On the shoulders of giants: a 1500-year-old aphorism." The American journal of medicine vol. 127,8 (2014): e41. doi: https://doi.org/10.1016/j.amjmed.2014.03.036
Dorizzi RM, Sette P, Azzini AM. On the shoulders of giants: a 1500-year-old aphorism. Am J Med. 2014 Aug;127(8):e41. doi: 10.1016/j.amjmed.2014.03.036. PMID: 25107403.
Copy Download .nbib Format: NLM
Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia.

American journal of hematology

Chyla B, Daver N, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A, Konopleva M, Popovic R.
PMID: 29770480
Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25146. Epub 2018 May 17.

No abstract available.

Cite
Chyla B, Daver N, Doyle K, et al. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018;doi: 10.1002/ajh.25146.
Chyla, B., Daver, N., Doyle, K., McKeegan, E., Huang, X., Ruvolo, V., Wang, Z., Chen, K., Souers, A., Leverson, J., Potluri, J., Boghaert, E., Bhathena, A., Konopleva, M., & Popovic, R. (2018). Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. American journal of hematology, . https://doi.org/10.1002/ajh.25146
Chyla, Brenda, et al. "Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25146
Chyla B, Daver N, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A, Konopleva M, Popovic R. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25146. Epub 2018 May 17. PMID: 29770480; PMCID: PMC6120451.
Copy Download .nbib Format: NLM
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

Frontiers in immunology

Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K.
PMID: 29379494
Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017.

Chronic lymphocytic leukemia (CLL) cells possess regulatory functions comparable to those of normal B10 cells, a regulatory B cell subset that suppresses effector T-cell function through STAT3-mediated IL-10 production. However, the mechanisms governing IL-10 production by CLL cells are...

Cite
Shaim H, Estrov Z, Harris D, et al. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol. 2018;8:1773doi: 10.3389/fimmu.2017.01773.
Shaim, H., Estrov, Z., Harris, D., Hernandez Sanabria, M., Liu, Z., Ruvolo, P., Thompson, P. A., Ferrajoli, A., Daher, M., Burger, J., Muftuoglu, M., Imahashi, N., Li, L., Liu, E., Alsuliman, A. S., Basar, R., Nassif Kerbauy, L., Sobieski, C., Gokdemir, E., Kondo, K., Wierda, W., Keating, M., Shpall, E. J., & Rezvani, K. (2017). The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Frontiers in immunology, 81773. https://doi.org/10.3389/fimmu.2017.01773
Shaim, Hila, et al. "The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide." Frontiers in immunology vol. 8 (2017): 1773. doi: https://doi.org/10.3389/fimmu.2017.01773
Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017. PMID: 29379494; PMCID: PMC5775272.
Copy Download .nbib Format: NLM
Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?.

Journal of thoracic disease

Ruvolo G, Pisano C, Balistreri CR, Maresi E, Triolo OF, Argano V, Bassano C, Vacirca SR, Nardi P, Orlandi A.
PMID: 29850167
J Thorac Dis. 2018 Apr;10(4):E270-E274. doi: 10.21037/jtd.2018.03.137.

We reported two cases of early structural valve degeneration (SVD) with Mitroflow prosthesis in aortic position in patients above the age of 65 years. Microscopic aspects have been analysed to investigate the intrinsic mechanism of SVD. New techniques to...

Cite
Ruvolo G, Pisano C, Balistreri CR, et al. Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?. J Thorac Dis. 2018;10(4):E270-E274doi: 10.21037/jtd.2018.03.137.
Ruvolo, G., Pisano, C., Balistreri, C. R., Maresi, E., Triolo, O. F., Argano, V., Bassano, C., Vacirca, S. R., Nardi, P., & Orlandi, A. (2018). Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?. Journal of thoracic disease, 10(4), E270-E274. https://doi.org/10.21037/jtd.2018.03.137
Ruvolo, Giovanni, et al. "Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?." Journal of thoracic disease vol. 10,4 (2018): E270-E274. doi: https://doi.org/10.21037/jtd.2018.03.137
Ruvolo G, Pisano C, Balistreri CR, Maresi E, Triolo OF, Argano V, Bassano C, Vacirca SR, Nardi P, Orlandi A. Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?. J Thorac Dis. 2018 Apr;10(4):E270-E274. doi: 10.21037/jtd.2018.03.137. PMID: 29850167; PMCID: PMC5949512.
Copy Download .nbib Format: NLM
Antiphospholipid syndrome: state of the art on clinical practice guidelines.

RMD open

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.
PMID: 30402272
RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN...

Cite
Limper M, Scirè CA, Talarico R, et al. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000785doi: 10.1136/rmdopen-2018-000785.
Limper, M., Scirè, C. A., Talarico, R., Amoura, Z., Avcin, T., Basile, M., Burmester, G., Carli, L., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Dörner, T., Fonseca, J. E., Galetti, I., Hachulla, E., Launay, D., Lourenco, F., Macieira, C., Meroni, P., Montecucco, C. M., Moraes-Fontes, M. F., Mouthon, L., Nalli, C., Ramoni, V., Tektonidou, M., van Laar, J. M., Bombardieri, S., Schneider, M., Smith, V., Vieira, A., Cutolo, M., Mosca, M., & Tincani, A. (2018). Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD open, 4e000785. https://doi.org/10.1136/rmdopen-2018-000785
Limper, Marteen, et al. "Antiphospholipid syndrome: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000785. doi: https://doi.org/10.1136/rmdopen-2018-000785
Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018. PMID: 30402272; PMCID: PMC6203101.
Copy Download .nbib Format: NLM
Sjögren's syndrome: state of the art on clinical practice guidelines.

RMD open

Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X.
PMID: 30402274
RMD Open. 2018 Oct 18;4:e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018.

Sjögren's syndrome (SS) is a complex autoimmune rheumatic disease that specifically targets salivary and lachrymal glands. As such, patients typically had ocular and oral dryness and salivary gland swelling. Moreover, skin, nasal and vaginal dryness are frequently present. In...

Cite
Romão VC, Talarico R, Scirè CA, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000789doi: 10.1136/rmdopen-2018-000789.
Romão, V. C., Talarico, R., Scirè, C. A., Vieira, A., Alexander, T., Baldini, C., Gottenberg, J. E., Gruner, H., Hachulla, E., Mouthon, L., Orlandi, M., Pamfil, C., Pineton de Chambrun, M., Taglietti, M., Toplak, N., van Daele, P., van Laar, J. M., Bombardieri, S., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Mariette, X. (2018). Sjögren's syndrome: state of the art on clinical practice guidelines. RMD open, 4e000789. https://doi.org/10.1136/rmdopen-2018-000789
Romão, Vasco C, et al. "Sjögren's syndrome: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000789. doi: https://doi.org/10.1136/rmdopen-2018-000789
Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018. PMID: 30402274; PMCID: PMC6203093.
Copy Download .nbib Format: NLM
Relapsing polychondritis: state of the art on clinical practice guidelines.

RMD open

Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, Launay D, Mathian A, Mattews L, Ponte C, Toniati P, Bombardieri S, Frank C, Schneider M, Smith V, Cutolo M, Mosca M, Arnaud L.
PMID: 30402273
RMD Open. 2018 Oct 18;4:e000788. doi: 10.1136/rmdopen-2018-000788. eCollection 2018.

Due to the rarity of relapsing polychondritis (RP), many unmet needs remain in the management of RP. Here, we present a systematic review of clinical practice guidelines (CPGs) published for RP, as well as a list of the most...

Cite
Rednic S, Damian L, Talarico R, et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000788doi: 10.1136/rmdopen-2018-000788.
Rednic, S., Damian, L., Talarico, R., Scirè, C. A., Tobias, A., Costedoat-Chalumeau, N., Launay, D., Mathian, A., Mattews, L., Ponte, C., Toniati, P., Bombardieri, S., Frank, C., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Arnaud, L. (2018). Relapsing polychondritis: state of the art on clinical practice guidelines. RMD open, 4e000788. https://doi.org/10.1136/rmdopen-2018-000788
Rednic, Simona, et al. "Relapsing polychondritis: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000788. doi: https://doi.org/10.1136/rmdopen-2018-000788
Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, Launay D, Mathian A, Mattews L, Ponte C, Toniati P, Bombardieri S, Frank C, Schneider M, Smith V, Cutolo M, Mosca M, Arnaud L. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000788. doi: 10.1136/rmdopen-2018-000788. eCollection 2018. PMID: 30402273; PMCID: PMC6203097.
Copy Download .nbib Format: NLM
Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement.

Journal of thoracic disease

Nardi P, Vacirca SR, Russo M, Colella DF, Bassano C, Scafuri A, Pellegrino A, Melino G, Ruvolo G.
PMID: 29707299
J Thorac Dis. 2018 Mar;10(3):1490-1499. doi: 10.21037/jtd.2018.03.67.

BACKGROUND: Myocardial protection techniques during cardiac arrest have been extensively investigated in the clinical setting of coronary revascularization. Fewer studies have been carried out of patients affected by left ventricular hypertrophy, where the choice of type and temperature of...

Cite
Nardi P, Vacirca SR, Russo M, et al. Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement. J Thorac Dis. 2018;10(3):1490-1499doi: 10.21037/jtd.2018.03.67.
Nardi, P., Vacirca, S. R., Russo, M., Colella, D. F., Bassano, C., Scafuri, A., Pellegrino, A., Melino, G., & Ruvolo, G. (2018). Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement. Journal of thoracic disease, 10(3), 1490-1499. https://doi.org/10.21037/jtd.2018.03.67
Nardi, Paolo, et al. "Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement." Journal of thoracic disease vol. 10,3 (2018): 1490-1499. doi: https://doi.org/10.21037/jtd.2018.03.67
Nardi P, Vacirca SR, Russo M, Colella DF, Bassano C, Scafuri A, Pellegrino A, Melino G, Ruvolo G. Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement. J Thorac Dis. 2018 Mar;10(3):1490-1499. doi: 10.21037/jtd.2018.03.67. PMID: 29707299; PMCID: PMC5906273.
Copy Download .nbib Format: NLM
[No title available]

One health (Amsterdam, Netherlands)

Leggewie M, Badusche M, Rudolf M, Jansen S, Börstler J, Krumkamp R, Huber K, Krüger A, Schmidt-Chanasit J, Tannich E, Becker SC.
PMID: 28616480
One Health. 2016 Apr 20;2:88-94. doi: 10.1016/j.onehlt.2016.04.001. eCollection 2016 Dec.

West Nile virus (WNV), a

Cite
Leggewie M, Badusche M, Rudolf M, et al. . One Health. 2016;2:88-94doi: 10.1016/j.onehlt.2016.04.001.
Leggewie, M., Badusche, M., Rudolf, M., Jansen, S., Börstler, J., Krumkamp, R., Huber, K., Krüger, A., Schmidt-Chanasit, J., Tannich, E., & Becker, S. C. (2016). . One health (Amsterdam, Netherlands), 288-94. https://doi.org/10.1016/j.onehlt.2016.04.001
Leggewie, Mayke, et al. "." One health (Amsterdam, Netherlands) vol. 2 (2016): 88-94. doi: https://doi.org/10.1016/j.onehlt.2016.04.001
Leggewie M, Badusche M, Rudolf M, Jansen S, Börstler J, Krumkamp R, Huber K, Krüger A, Schmidt-Chanasit J, Tannich E, Becker SC. . One Health. 2016 Apr 20;2:88-94. doi: 10.1016/j.onehlt.2016.04.001. eCollection 2016 Dec. PMID: 28616480; PMCID: PMC5462652.
Copy Download .nbib Format: NLM
Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma.

Biomedical optics express

Rizzo R, Alvaro M, Danz N, Napione L, Descrovi E, Schmieder S, Sinibaldi A, Rana S, Chandrawati R, Munzert P, Schubert T, Maillart E, Anopchenko A, Rivolo P, Mascioletti A, Förster E, Sonntag F, Stevens MM, Bussolino F, Michelotti F.
PMID: 29552391
Biomed Opt Express. 2018 Jan 08;9(2):529-542. doi: 10.1364/BOE.9.000529. eCollection 2018 Feb 01.

Quantitative detection of angiogenic biomarkers provides a powerful tool to diagnose cancers in early stages and to follow its progression during therapy. Conventional tests require trained personnel, dedicated laboratory equipment and are generally time-consuming. Herein, we propose our developed...

Cite
Rizzo R, Alvaro M, Danz N, et al. Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomed Opt Express. 2018;9(2):529-542doi: 10.1364/BOE.9.000529.
Rizzo, R., Alvaro, M., Danz, N., Napione, L., Descrovi, E., Schmieder, S., Sinibaldi, A., Rana, S., Chandrawati, R., Munzert, P., Schubert, T., Maillart, E., Anopchenko, A., Rivolo, P., Mascioletti, A., Förster, E., Sonntag, F., Stevens, M. M., Bussolino, F., & Michelotti, F. (2018). Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomedical optics express, 9(2), 529-542. https://doi.org/10.1364/BOE.9.000529
Rizzo, Riccardo, et al. "Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma." Biomedical optics express vol. 9,2 (2018): 529-542. doi: https://doi.org/10.1364/BOE.9.000529
Rizzo R, Alvaro M, Danz N, Napione L, Descrovi E, Schmieder S, Sinibaldi A, Rana S, Chandrawati R, Munzert P, Schubert T, Maillart E, Anopchenko A, Rivolo P, Mascioletti A, Förster E, Sonntag F, Stevens MM, Bussolino F, Michelotti F. Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomed Opt Express. 2018 Jan 08;9(2):529-542. doi: 10.1364/BOE.9.000529. eCollection 2018 Feb 01. PMID: 29552391; PMCID: PMC5854056.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 283 entries